Physician to Discuss “Sudden Cardiac Arrest” in Weslaco Feb. 7

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

DHR Health stands at the forefront of minimally invasive robotic surgery in South Texas, exemplified by its Institute of Robotic Surgery, which successfully completes over 1,000 robotic cases annually. With the recent inauguration of DHR Health Brownsville, this advanced expertise in Minimally Invasive Surgical procedures is extending its reach to the lower Rio Grande Valley. In a groundbreaking milestone last month, Dr. Rene Luna conducted DHR Health Brownsville's inaugural Robotic Surgery.

Agustin Guzman and Juan Garza of Pieology said they receive so much support from their communities and businesses, including DHR Health employees who love their pizza, and wanted to give back in a way that offers the hospital system some additional resources to help keep staff and patients protected from the spread of COVID-19 or any other viruses.